Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment

Jens Hemmingsson; Johanna Svensson; Andreas Hallqvist; Katja Smits; Viktor Johanson; Peter Bernhardt

doi:10.2967/jnumed.123.265484

Research ArticleClinical Investigation

Open Access

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [¹⁷⁷Lu]Lu-DOTATATE Treatment

Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, Katja Smits, Viktor Johanson and Peter Bernhardt

Journal of Nuclear Medicine June 2023, jnumed.123.265484; DOI: https://doi.org/10.2967/jnumed.123.265484

Jens Hemmingsson

1Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johanna Svensson

2Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

3Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Hallqvist

2Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

3Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katja Smits

1Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Viktor Johanson

4Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter Bernhardt

1Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden;

5Department of Medical Physics and Medical Bioengineering, Sahlgrenska University Hospital, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [¹⁷⁷Lu]Lu-DOTATATE Treatment

Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, Katja Smits, Viktor Johanson, Peter Bernhardt

Journal of Nuclear Medicine Jun 2023, jnumed.123.265484; DOI: 10.2967/jnumed.123.265484

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [¹⁷⁷Lu]Lu-DOTATATE Treatment

Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, Katja Smits, Viktor Johanson, Peter Bernhardt

Journal of Nuclear Medicine Jun 2023, jnumed.123.265484; DOI: 10.2967/jnumed.123.265484

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

Comparison of the tolerability of 161Tb- and 177Lu-labeled somatostatin analogues in the preclinical setting
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study

Google Scholar

Keywords

dosimetry
red marrow
177Lu
SPECT
DOTATATE

Main menu

User menu

Search

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [¹⁷⁷Lu]Lu-DOTATATE Treatment

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords